INNV Q3 2026 Earnings Call Summary

Total Revenue: Approximately $252 million, a 15.5% increase year-over-year.
Adjusted EBITDA: $30.5 million, up from $10.8 million in Q3 2025.
Center-Level Contribution Margin: $61 million (24.2% of revenue), up from $40.7 million (18.7% of revenue) in Q3 2025.
Net Loss: $29.9 million, compared to a net loss of $11.1 million in Q3 2025.
Participants Served: Approximately 8,050, a 6.9% increase year-over-year.
Cash Flow from Operations: Positive $18.1 million.

InnovAge is experiencing steady momentum and operational improvements, attributed to investments in clinical teams and technology, including AI applications for care coordination.
The company is expanding its footprint with new centers in Florida and is focused on enhancing participant experience and care quality.
Ongoing investments are being made in measuring clinical outcomes and improving operational efficiencies.
The management emphasized the importance of aligning financial performance with quality outcomes for participants.

Fiscal Year 2026 Guidance: Revenue is now expected to be between $950 million and $975 million, and adjusted EBITDA is projected to be in the range of $85 million to $90 million.
Fiscal Year 2027 Considerations: Anticipated Medicare rate increases of 1.5% to 2%, with potential Medicaid rate pressures due to state budget constraints. The company is preparing for a more challenging rate environment.

Net Loss Increase: The net loss widened from the previous year, raising concerns about profitability.
Litigation Liabilities: A significant increase in corporate general and administrative expenses (up 98.3% year-over-year) was primarily driven by litigation liabilities.
Rate Environment: The company anticipates lower Medicaid rate increases in fiscal 2027, which could pressure top-line growth. There are indications of increasing budget pressures from state partners.
Cost Management: While cost growth has been managed effectively, there are risks associated with maintaining this trend in a potentially inflationary environment.

Management acknowledged the complexities of the upcoming rate environment for fiscal 2027, emphasizing their commitment to maintaining quality care while navigating these challenges.
The discussion highlighted the importance of participant experience and operational efficiency as key drivers for growth, even in a challenging financial landscape.
The company is exploring various growth strategies, including M&A, partnerships, and policy modernization, to expand its reach and enhance service delivery.
There was a focus on the sustainability of improved risk scores and Medicaid rates, with management expressing cautious optimism about maintaining these favorable trends moving forward.

INNV — InnovAge Holding Corp.